Wordt geladen...
Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
Vulvar cancer remains a rare entity and treatment options for advanced disease are limited. This case report highlights the excellent response of two patients with FIGO Stage IV vulvar cancer treated with neoadjuvant paclitaxel/carboplatin/bevacizumab chemotherapy. While definitive conclusions are i...
Bewaard in:
| Gepubliceerd in: | Gynecol Oncol Rep |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7498849/ https://ncbi.nlm.nih.gov/pubmed/32984493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100631 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|